1. Home
  2. APRE vs BLIN Comparison

APRE vs BLIN Comparison

Compare APRE & BLIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aprea Therapeutics Inc.

APRE

Aprea Therapeutics Inc.

HOLD

Current Price

$0.80

Market Cap

10.8M

Sector

Health Care

ML Signal

HOLD

Logo Bridgeline Digital Inc.

BLIN

Bridgeline Digital Inc.

N/A

Current Price

$0.98

Market Cap

12.1M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
APRE
BLIN
Founded
2006
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
10.8M
12.1M
IPO Year
2019
2018

Fundamental Metrics

Financial Performance
Metric
APRE
BLIN
Price
$0.80
$0.98
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$4.10
$4.62
AVG Volume (30 Days)
478.0K
55.7K
Earning Date
05-13-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
21.22
N/A
EPS
N/A
N/A
Revenue
N/A
$13,568,000.00
Revenue This Year
N/A
$22.67
Revenue Next Year
N/A
$21.08
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.55
$0.69
52 Week High
$1.69
$1.59

Technical Indicators

Market Signals
Indicator
APRE
BLIN
Relative Strength Index (RSI) 55.33 39.09
Support Level $0.74 $0.95
Resistance Level $0.81 $1.08
Average True Range (ATR) 0.10 0.05
MACD 0.01 0.00
Stochastic Oscillator 33.80 21.00

Price Performance

Historical Comparison
APRE
BLIN

About APRE Aprea Therapeutics Inc.

Aprea Therapeutics Inc is a clinical-stage precision medicine oncology company focused on the discovery and development of targeted therapies for patients with biomarker-defined cancers. It develops small molecule inhibitors designed to exploit genetic mutations in cancer to widen the therapeutic window and is intended to make treatments more effective at destroying cancer cells while sparing healthy tissue. The company's pipeline of clinical and preclinical programs includes APR-1051, a WEE1 inhibitor; ATRN-119 (Mosipasertib), an oral small molecule inhibitor of ataxia telangiectasia and Rad3-related, or ATR; and an early-stage program, APR-1602. These candidates are being developed for broad applications in cancer treatment.

About BLIN Bridgeline Digital Inc.

Bridgeline Digital Inc is a AI-powered marketing technology company that offers a suite of products that help companies grow online revenue by driving more traffic to their websites, converting more visitors to purchasers, and increasing average order value. Company software is available through a cloud-based Software as a Service (SaaS) model. It helps to maximize the performance of critical websites, intranets, and online stores. The company generates revenue from digital engagement services, subscription, perpetual licenses, maintenance, and hosting. Geographically, it derives a majority of revenue from the United States.

Share on Social Networks: